Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Individualized Versus Non-Individualized Resistance Training

5 de noviembre de 2026 actualizado por: Christophe Delecluse, Universitaire Ziekenhuizen KU Leuven

Una intervención personalizada para prevenir la disminución de la potencia muscular y la capacidad funcional relacionada con la edad

Preserving functional ability is crucial for healthy aging. Unfortunately, age-related decreases in muscle power often lead to declines in functional ability. As power is the product of force and velocity, decreases in power can originate from changes in muscle force, contraction velocity, or both, varying between individuals. The primary method to prevent functional disability is power-based resistance training. Although training interventions are effective for most older adults, they do not induce substantial improvements in a subset of the population. These inconsistent outcomes may arise from neglecting the observed differences in the force-velocity (F-V) profiles between individuals. Therefore, this study provides a novel approach to resistance exercise, in which exercise dose is tailored according to the individual's F-V profile. The effectiveness of the tailored method will be assessed in a randomized control trial, comparing the effects of an individualized and a non-individualized 12-week training intervention on muscle power parameters and functional ability.

Descripción general del estudio

Tipo de estudio

Intervencionista

Inscripción (Actual)

80

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Vlaams-Brabant
      • Leuven, Vlaams-Brabant, Bélgica, 3000
        • KU Leuven - Department of Movement Sciences

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

65 años y mayores (Adulto Mayor)

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Community-dwelling adults
  • At least 65 years old

Exclusion Criteria:

  • Systematic engagement in resistance exercise during the past year
  • Unstable cardiovascular disease, neuromuscular disease, acute infection or fever
  • Recent surgery
  • Lower-extremity injuries
  • Low levels of functional ability (i.e., SPPB score ≤ 9)
  • Cognitive malfunctioning (i.e., Mini-Mental State Examination < 24)

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Prevención
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Individualized resistance exercise program

Individualized exercise dose. All individuals perform resistance exercises at a load that targets their deficit. Individuals with a velocity deficit train at low loads while individuals with a force deficit train at high loads.

2x/week, 35-45 min sessions, on leg press machine

Comparador activo: Non-individualized resistance exercise program

Non-individualized exercise dose. All individuals perform resistance exercises at a load that does not target their deficit. Individuals with a velocity deficit train at high loads while individuals with a force deficit train at low loads.

2x/week, 35-45 min sessions, on leg press machine

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Maximal power (Pmax)
Periodo de tiempo: Change from baseline at 6 and 12 weeks

Participants performed explosive unilateral leg extensions with the dominant leg at five submaximal loads on a pneumatic leg press (Leg Press Air 400, Keiser, USA). Submaximal loads were scaled to the estimated maximal isometric force derived from the familiarization session. The three lighter loads were performed three times each and the two heavier loads twice, with the repetition yielding the highest mean concentric velocity retained for analysis. Participants subsequently performed single repetitions at incrementally increasing loads until 1-RM was reached. Rest intervals were adjusted according to the load of the preceding trial: 60 s after the three lightest loads, 90 s after the two heavier loads, and 120 s during the incremental trials leading to 1-RM. For each load, the mean concentric velocity of the best trial was used to establish the individual force-velocity (F-V) relationship using linear regression, from which the maximal power (Pmax; W) was estimated.

Change from baseline at 6 and 12 weeks
Maximal isometric force (F0)
Periodo de tiempo: Change from baseline at 6 and 12 weeks

Participants performed explosive unilateral leg extensions with the dominant leg at five submaximal loads on a pneumatic leg press (Leg Press Air 400, Keiser, USA). Submaximal loads were scaled to the estimated maximal isometric force derived from the familiarization session. The three lighter loads were performed three times each and the two heavier loads twice, with the repetition yielding the highest mean concentric velocity retained for analysis. Participants subsequently performed single repetitions at incrementally increasing loads until 1-RM was reached. Rest intervals were adjusted according to the load of the preceding trial: 60 s after the three lightest loads, 90 s after the two heavier loads, and 120 s during the incremental trials leading to 1-RM. For each load, the mean concentric velocity of the best trial was used to establish the individual force-velocity (F-V) relationship using linear regression, from which maximal isometric force (F0; N) was estimated.

Change from baseline at 6 and 12 weeks
Maximal unloaded velocity (V0)
Periodo de tiempo: Change from baseline at 6 and 12 weeks

Participants performed explosive unilateral leg extensions with the dominant leg at five submaximal loads on a pneumatic leg press (Leg Press Air 400, Keiser, USA). Submaximal loads were scaled to the estimated maximal isometric force derived from the familiarization session. The three lighter loads were performed three times each and the two heavier loads twice, with the repetition yielding the highest mean concentric velocity retained for analysis. Participants subsequently performed single repetitions at incrementally increasing loads until 1-RM was reached. Rest intervals were adjusted according to the load of the preceding trial: 60 s after the three lightest loads, 90 s after the two heavier loads, and 120 s during the incremental trials leading to 1-RM. For each load, the mean concentric velocity of the best trial was used to establish the individual force-velocity (F-V) relationship using linear regression, from which maximal unloaded velocity (V0; m/s) was estimated.

Change from baseline at 6 and 12 weeks
Force-velocity slope
Periodo de tiempo: Change from baseline at 6 and 12 weeks

Participants performed explosive unilateral leg extensions with the dominant leg at five submaximal loads on a pneumatic leg press (Leg Press Air 400, Keiser, USA). Submaximal loads were scaled to the estimated maximal isometric force derived from the familiarization session. The three lighter loads were performed three times each and the two heavier loads twice, with the repetition yielding the highest mean concentric velocity retained for analysis. Participants subsequently performed single repetitions at incrementally increasing loads until 1-RM was reached. Rest intervals were adjusted according to the load of the preceding trial: 60 s after the three lightest loads, 90 s after the two heavier loads, and 120 s during the incremental trials leading to 1-RM. For each load, the mean concentric velocity of the best trial was used to establish the individual force-velocity (F-V) relationship using linear regression, from which the F-V slope (Ns/m) was derived.

Change from baseline at 6 and 12 weeks

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Short Physical Performance Battery (SPPB)
Periodo de tiempo: Score at baseline

Total score on the SPPB (min 0, max 12, higher scores indicate better performance)

Score at baseline
Hand grip strength
Periodo de tiempo: Change from baseline at 6 and 12 weeks

Maximal grip strength (kg) of the dominant hand using an isometric dynamometer adjusted for hand size

Change from baseline at 6 and 12 weeks
Maximal gait speed
Periodo de tiempo: Change from baseline at 6 and 12 weeks

The average time (s) to walk 10m as fast as possible

Change from baseline at 6 and 12 weeks
Countermovement jump
Periodo de tiempo: Change from baseline at 6 and 12 weeks

The jump height (mm) in a countermovement jump

Change from baseline at 6 and 12 weeks
Timed up-and-go
Periodo de tiempo: Change from baseline at 6 and 12 weeks

The time (s) needed to stand up from a chair, walk 3 m, turn, walk back and sit down again as fast as possible

Change from baseline at 6 and 12 weeks
5-repetition sit-to-stand time
Periodo de tiempo: Change from baseline at 6 and 12 weeks

The time (s) needed to complete the 5-repetition sit-to-stand test

Change from baseline at 6 and 12 weeks
5-repetition sit-to-stand power
Periodo de tiempo: Change from baseline at 6 and 12 weeks

The average power (watt) produced during the 5-repetition sit-to-stand test

Change from baseline at 6 and 12 weeks
30-second sit-to-stand repetitions
Periodo de tiempo: Change from baseline at 6 and 12 weeks

The number of repetitions completed during the 30-second sit-to-stand test

Change from baseline at 6 and 12 weeks
30-second sit-to-stand power
Periodo de tiempo: Change from baseline at 6 and 12 weeks

The average power (watt) produced during the 30-second sit-to-stand test

Change from baseline at 6 and 12 weeks
Stair ascent time
Periodo de tiempo: Change from baseline at 6 and 12 weeks

The time (s) needed to ascend a flight of stairs

Change from baseline at 6 and 12 weeks
Stair ascent power
Periodo de tiempo: Change from baseline at 6 and 12 weeks

The average power (Watt) produced during the stair ascent test

Change from baseline at 6 and 12 weeks
Exercise adherence
Periodo de tiempo: Total adherence over 12-week period

Number of sessions attended as a percentage of total sessions planned

Total adherence over 12-week period
Absolute training load
Periodo de tiempo: Consistently recorded throughout the 12-week intervention

The absolute load (kg) used during training sessions

Consistently recorded throughout the 12-week intervention
Relative training load
Periodo de tiempo: Consistently recorded throughout the 12-week intervention

The relative load (%1RM) used during training sessions

Consistently recorded throughout the 12-week intervention
Number of repetitions
Periodo de tiempo: Consistently recorded throughout the 12-week intervention

The number of repetitions (n) completed per set

Consistently recorded throughout the 12-week intervention
Highest movement velocity within a set
Periodo de tiempo: Consistently recorded throughout the 12-week intervention

The velocity (m/s) of the fastest repetition in a set (Vmax)

Consistently recorded throughout the 12-week intervention
Lowest movement velocity within a set
Periodo de tiempo: Consistently recorded throughout the 12-week intervention

The velocity (m/s) of the slowest repetition in a set (Vmin)

Consistently recorded throughout the 12-week intervention
Velocity loss
Periodo de tiempo: Consistently recorded throughout the 12-week intervention

The percentage difference between the highest and lowest movement velocity in a set = ([Vmax - Vmin] / Vmax) × 100

Consistently recorded throughout the 12-week intervention
Set-volume index
Periodo de tiempo: Consistently recorded throughout the 12-week intervention

The number of repetitions × relative load (%1-RM) per set

Consistently recorded throughout the 12-week intervention
Session-volume index
Periodo de tiempo: Consistently recorded throughout the 12-week intervention

The sum of set volumes per session

Consistently recorded throughout the 12-week intervention

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

20 de mayo de 2024

Finalización primaria (Actual)

4 de diciembre de 2025

Finalización del estudio (Actual)

4 de diciembre de 2025

Fechas de registro del estudio

Enviado por primera vez

5 de marzo de 2024

Primero enviado que cumplió con los criterios de control de calidad

5 de junio de 2024

Publicado por primera vez (Actual)

10 de junio de 2024

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

6 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

5 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • S68434

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir